AlphaCrest Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FISV
Fiserv Inc
FISV
|
+$12.3M |
| 2 |
UnitedHealth
UNH
|
+$11.6M |
| 3 |
Oracle
ORCL
|
+$11M |
| 4 |
Baxter International
BAX
|
+$10.7M |
| 5 |
Archer Daniels Midland
ADM
|
+$10.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Morgan Stanley
MS
|
+$17.3M |
| 2 |
Nike
NKE
|
+$16.2M |
| 3 |
Merck
MRK
|
+$13.4M |
| 4 |
Comcast
CMCSA
|
+$12.8M |
| 5 |
Microsoft
MSFT
|
+$9.26M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.18% |
| 2 | Financials | 14.64% |
| 3 | Healthcare | 14.37% |
| 4 | Industrials | 13.29% |
| 5 | Consumer Discretionary | 10.67% |
Similar funds
AlphaCrest Capital Management's Q2 2021 Portfolio in Review
As of Q2 2021, AlphaCrest Capital Management held 1,402 positions worth $2.33B, up 30% from $1.79B the previous quarter. Its ten largest holdings account for 5.9% of the portfolio.
AlphaCrest Capital Management deployed $466M of net new capital in Q2 2021, opening 244 new positions and adding to 583 existing holdings. Its largest new stake was Nucor: 85,982 shares worth $8.25M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Morgan Stanley, an estimated $17.3M trimmed.
- AlphaCrest Capital Management's largest Q2 2021 buy was Nucor: 85,982 shares worth $8.25M.
- AlphaCrest Capital Management added most to Fiserv Inc in Q2 2021, an estimated $12.3M increase.
- AlphaCrest Capital Management's biggest Q2 2021 reduction was Morgan Stanley, cutting an estimated $17.3M.
- AlphaCrest Capital Management fully exited Merck in Q2 2021, selling an estimated $13.4M.
- AlphaCrest Capital Management's ten largest holdings make up 5.9% of its $2.33B portfolio in Q2 2021.
- AlphaCrest Capital Management opened 244 new positions and closed 199 in Q2 2021.
- AlphaCrest Capital Management's portfolio value rose 30% quarter-over-quarter to $2.33B.
Based on AlphaCrest Capital Management's 13F filing for Q2 2021, filed 12 Aug 2021.